Baxter International Inc (BAX)

Currency in USD
18.47
-0.69(-3.60%)
Closed·
18.45-0.02(-0.11%)
·

BAX Earnings

Latest Release
Oct 30, 2025
EPS / Forecast
0.69 / 0.60
Revenue / Forecast
2.84B / 2.88B
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
12/2025--/0.698--/3.01B----Free Sign Up
09/20250.69/0.62.84B/2.88B+15%-1.39%Free Sign Up
06/20250.59/0.612.81B/2.82B-3.28%-0.35%Free Sign Up
03/20250.13/0.482.63B/2.59B-72.92%+1.54%Free Sign Up
12/20240.58/0.522.75B/2.67B+11.54%+3%Free Sign Up
09/20240.8/0.783.85B/3.85B+2.56%0%Free Sign Up
06/20240.68/0.663.81B/3.75B+3.03%+1.6%Free Sign Up
03/20240.65/0.613.59M/3.55B+6.56%-99.9%Free Sign Up
12/20230.88/0.863.89B/3.81B+2.33%+2.1%Free Sign Up
09/20230.68/0.673.71B/3.7B+1.49%+0.27%Free Sign Up

All numbers in USD

Baxter International Inc Earnings Call Summary for Q3/2025

  • Baxter reported Q3 2025 EPS of $0.69, beating $0.60 forecast, while revenue of $2.84B missed projections by 1.39%, triggering a 16.06% pre-market stock decline
  • Global sales increased 5% on reported basis and 2% operationally, with adjusted EPS up 41% YoY despite the company lowering full-year operational sales growth forecast to 1-2%
  • CEO Andrew Heider acknowledged dissatisfaction with current performance, emphasizing the company is 'on a journey to build a better Baxter'
  • Baxter plans to reduce dividends starting January 2026 and targets achieving 3x net leverage by end of 2026, with an Investor Day planned for 2026
  • Key challenges include continued hold on Novum IQ pump shipments, softness in pharmaceutical products, and fluid conservation efforts affecting market demand
Last Updated: 30/10/2025, 15:14
Read Full Transcript

FAQ

What Is Baxter's Earnings Per Share (TTM)?

The Baxter EPS (TTM) is -0.67.

When Is The Next Baxter Earnings Date?

Baxter will release its next earnings report on 11 Feb 2026.

What Is Baxter’s Revenue Forecasts For Upcoming Quarters?

Baxter’s revenue forecast is 3.01B.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.